TrueNorth Advises Enzyme Company BioResource International on its sale to Novus International
Stamford, CT – March, 2024: TrueNorth Capital Partners LLC is pleased to announce that its wholly-owned subsidiary, TNCP, LLC (“TrueNorth”) acted as exclusive financial advisor to BioResource International, Inc. (“BRI”) on its sale to Novus International, Inc (“NOVUS”), which is owned